Filiz Koça*, Deni˙z Yerdelenb & Zafer Kocca Departments of Neurology, Cukurova University Medical School, Adana, Turkeyb Department Neurology, Baskent University Medical School, Adana, Turkeyc Department of Radiology, Başkent University Faculty of Medicine, Adana, Turkey† Correspondence: Filiz Koç, Departments of Neurology, Cukurova University Medical School, 01330, Adana, TurkeyThe neurofibromatoses are genetic disorders of the nervous system that primarily affect the development and growth of neural (nerve) cell tissues. The neurofibromatoses are classified as neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2). NF1 is the more common type of the neurofibromatoses. The gene responsible for NF1 is located on the chromosome region 17q11.2 and for familial moyamoya disease on chromosome 17q25. This article reports on a 20-year-old female with neurofibromatosis-1 who developed moyamoya syndrome. More extensive reports and further investigations of such families having this combination will certainly provide a better understanding of this link in the near future.
No takes yet. Share an insight, caveat, or question.
Koç et al. (2008) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: